Glaxosmithkline Pharmaceuticals has reported results for first quarter ended June 30, 2022.
The company has reported a marginal fall of 1.43% in its net profit at Rs 118.68 crore for the quarter under review as compared to Rs 120.40 crore for the same quarter in the previous year. However, total income of the company increased by 3.23% at Rs 757.25 crore for Q1FY23 as compared Rs 733.57 crore for the corresponding quarter previous year.
On the consolidated basis, the company has reported a marginal fall of 1.49% in its net profit at Rs 119.28 crore for the quarter under review as compared to Rs 121.08 crore for the same quarter in the previous year. However, total income of the company increased by 3.01% at Rs 772.71 crore for Q1FY23 as compared Rs 750.10 crore for the corresponding quarter previous year.
